Corcept Therapeutics (CORT) News
NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
121.19+2.65 (+2.24%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CORT news summary
We found 3 recent headlines mentioning Corcept Therapeutics (CORT): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, CORT is up 2.24% at $121.19. The most recent story, "The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies", was published by Nasdaq on Oct 5, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Corcept Therapeutics headlines
- The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health CompaniesHealthcare stocks like Abbott Laboratories offer low-beta exposure as rate hike fears and inflation keep markets volatile.NasdaqABT, CORT, BHC, PGEN
- 4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate HikeABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.NasdaqABT, CORT, BHC, PGEN
- Biotech Stocks At 52-Week Highs - ELOX, PRLD, ARGX, BOLD, CORT(RTTNews) - The following biotech stocks reached a 52-week high on August 21, 2026, as new trials continued enrolment and companies released positive clinical research data.NasdaqARGX, BOLD, CORT, ELOX